DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News Feed
EPG Online Disease Knowledge Centres Feed Knowledge Centres Feed
EPG Search
Frequent Searches:
Search
Languages

Browse Other Languages
YouTube - Featured Content

Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here

epgonline.org is not responsible for content on any 3rd party website

Alzheimer's Disease, understanding, management, diagnosis and treatment information Diabetes, understanding, management, diagnosis and treatment information Men's Health - understanding, management, diagnosis and treatment information Benign prostatic hyperplasia (BPH) - understanding, management, diagnosis and treatment information
Are you a Doctor or Healthcare Professional? Authorise Viewing

Please register to access disease diagnosis, patient management, physician tools.

By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M
N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

Drug details for : INDERAL (arrhythmia)
 
Drug class description :  Non-cardioselective b-blockers (beta-blockers).
Generic Name :  Propranolol - arrhythmias/MI/ cardiomyopathy
Drug description :  Inderal Tablets: pink f-c tablets marked with tablet name and strength. Inderal Injection: ampoules.
Presentation :  Inderal Tablets: Propranolol hydrochloride 10mg , 40mg , 80mg . Inderal Injection: Propranolol hydrochloride 1mg/mL.
Indications :  Prevention of myocardial reinfarction. Cardiac arrhythmias; hypertrophic obstructive cardiomyopathy.
Adult Dosage :  Reinfarction, 40 mg four times daily for two or three days starting 5 to 21 days after infarction, then 80 mg twice daily. Arrhythmias or cardiomyopathy, 10 - 40 mg three or four times daily.
Child Dosage :  Arrhythmias, 0 .25 - 0 .5 mg/kg body-weight three or four times daily.
Contra Indications :  2nd or 3rd degree AV block, sinus bradycardia, sick sinus syndrome, after prolonged fasting, severe uncompensated cardiac failure, cardiogenic shock, hypotension, untreated phaeochromocytoma. Generally contra-indicated in patients with obstructive airways disease or a history of bronchospasm. Known hypersensitivity. Prinzmetal's angina. Metabolic acidosis.
Special Precautions :  Poor cardiac reserve should be controlled with digitalis and diuretics. First degree AV block, portal hypertension. Diabetes; metabolic acidosis. Asthenic symptoms. Cerebrovascular insufficiency. Renal or hepatic impairment, thyrotoxicosis. General anaesthesia; consider withdrawal before elective surgery. Pregnancy, lactation. Withdraw gradually.
Interactions :  Clonidine withdrawal, verapamil, diltiazem, class II calcium antagonists, class I antiarrhythmics, cardiac depressant anaesthetics, hypoglycaemics, reserpine, other antihypertensives, ergot alkaloids, cimetidine, rifampicin, theophylline, warfarin, CNS depressants, sympathomimetics, indometacin (indomethacin), ibuprofen, chlorpromazine. Refer to Summary of Product Characteristics.
Adverse Reactions :  Cold extremities, sleep disturbances, bradycardia, bronchospasm, heart failure deterioration, postural hypotension, GI upset, alopecia, precipitation of heart block, exacerbation of intermittent claudication, Raynaud's phenomenon, confusion, dizziness, mood changes, nightmares, psychoses and hallucinations, purpura, thrombocytopenia, dry eyes, psoriasiform skin reactions, exacerbation of psoriasis, skin rashes, paraesthesia, visual disturbances, fatigue and/or lassitude, increase in antinuclear antibodies.
Manufacturer :  AstraZeneca
Drug Availability :  (POM)
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.

Already Registered?

Please log-in now using our member login box.

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

What's New!
Try EPG Mobile
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!